Tissue-type plasminogen activator (t-PA), is a serine proteinase that catal
yzes the initial and rate-limiting step in the fibrinolytic cascade. Its pl
asma activity is determined by the rate of release into the bloodstream,, t
he rate of inhibition by plasminogen-activator inhibitor type 1 (PAI-1) and
the rate of hepatic clearance. Two receptor systems contribute to the clea
rance of t-PA: the mannose receptor and the low-density lipoprotein recepto
r-related protein (LRP) that removes free t-PA as well as t-PA-PAI-1 comple
xes from the blood. During pregnancy a significant rise in the plasma level
s of pregnancy zone protein (PZP) is observed, while alpha (2)-macroglobuli
n (alpha (2)-M) remains constant. Interestingly, the fibrinolytic activity
is decreased during this period. In this context, we have recently demonstr
ated the in vitro formation of PZP-t-PA complexes. Here, we purified LRP fr
om human placenta by affinity chromatography and then analyzed the binding
specificity and affinity of PZP-proteinase complexes to the receptor by enz
yme immunoassay (EIA), Our results clearly established that the binding of
PZP-t-PA complexes to LRP was specific, saturable, and with K-d = 337 +/- 3
1 nM, Moreover, by using the same EIA, we further observed that this bindin
g was inhibited by receptor-associated protein. These data suggest that PZP
, by binding to t-PA and promoting its clearance via LRP, might contribute
in vivo to the downregulation of the fibrinolytic activity during pregnancy
, (C) 2001 Academic Press.